An algal lectin griffithsin inhibits Hantaan virus infection in vitro and in vivo
Yajing Zhao(The Affiliated Yongchuan Hospital of Chongqing Medical University), Fanglin Zhang(Central South University), Chuantao Ye(People 's Liberation Army 451 Hospital), Lianqing Zhang(Sichuan University), Wanying Li(Guangxi University), Yingfeng Lei(Air Force Medical University), Jia Li(National University of Singapore), He Liu(Renmin Hospital of Wuhan University), Hui Zhang(Edinburgh Napier University), Lu Lu(Shanghai Medical College of Fudan University), Jiaqi Liu(Inner Mongolia University of Science and Technology), Liang Zhang(Oregon State University), Wei Ye(Xi'an Medical University), Linfeng Cheng(Air Force Medical University), Yanxing Cai(Fudan University), Zhikai Xu(Air Force Medical University), Yuexiang Li(Northwest University), Yingjuan Wang(Northwest University), Ningbo Zhao(Air Force Medical University), Yangchao Dong(Air Force Medical University), Yuan Wang(First Affiliated Hospital Zhejiang University), Yamei Dang(Air Force Medical University)
Cited by 12
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400